Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion type Assertion NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_head.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion wasGeneratedBy ECO_0000203 NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_provenance.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion wasDerivedFrom befree-20140225 NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_provenance.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion SIO_000772 12242461 NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_provenance.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion evidence source_evidence_literature NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_provenance.
- NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_assertion description "[Ac-GIP and pGlu-GIP, show resistance to plasma dipeptidylpeptidase IV degradation, resulting in enhanced biological activity and improved antidiabetic potential in vivo, raising the possibility of their use in therapy of Type II (non-insulin-dependent) diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939886.RAPJSLXBjE96vLAqkUu45AW3Iw4OVd7GJJHA5a_r2CBrc130_provenance.